A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects
Clinical trial NCT03372629 · COMPLETED
Trial details
- NCT number
- NCT03372629
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-12
- Primary completion
- 2018-12-02
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.